Cubist Systematic Strategies’s Array Biopharma Inc ARRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-134,582
| Closed | -$6.24M | – | 2666 |
|
|
2019
Q2 | $6.24M | Buy |
134,582
+131,301
| +4,002% | +$6.08M | 0.11% | 231 |
|
|
2019
Q1 | $80K | Sell |
3,281
-21,860
| -87% | -$533K | ﹤0.01% | 2037 |
|
|
2018
Q4 | $358K | Buy |
+25,141
| New | +$358K | 0.02% | 1159 |
|
|
2018
Q3 | – | Sell |
-129,461
| Closed | -$2.17M | – | 2182 |
|
|
2018
Q2 | $2.17M | Buy |
129,461
+86,529
| +202% | +$1.45M | 0.11% | 224 |
|
|
2018
Q1 | $701K | Buy |
42,932
+41,601
| +3,126% | +$679K | 0.04% | 610 |
|
|
2017
Q4 | $17K | Sell |
1,331
-11,316
| -89% | -$145K | ﹤0.01% | 1844 |
|
|
2017
Q3 | $156K | Sell |
12,647
-53,160
| -81% | -$656K | 0.01% | 1531 |
|
|
2017
Q2 | $551K | Buy |
65,807
+48,542
| +281% | +$406K | 0.04% | 693 |
|
|
2017
Q1 | $154K | Buy |
17,265
+12,865
| +292% | +$115K | 0.01% | 1280 |
|
|
2016
Q4 | $39K | Buy |
+4,400
| New | +$39K | ﹤0.01% | 1602 |
|
|
2016
Q2 | – | Sell |
-11,531
| Closed | -$34K | – | 1978 |
|
|
2016
Q1 | $34K | Buy |
+11,531
| New | +$34K | ﹤0.01% | 1501 |
|
|
2015
Q4 | – | Sell |
-63,035
| Closed | -$287K | – | 2067 |
|
|
2015
Q3 | $287K | Buy |
63,035
+48,083
| +322% | +$219K | 0.01% | 1265 |
|
|
2015
Q2 | $108K | Buy |
+14,952
| New | +$108K | 0.01% | 1610 |
|